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Abstract
Study question Does cryoprotection of spermatozoa using a vitrification protocol with improved cryoprotective agents and a
novel device for large storage lead to better outcomes than conventional slow freezing?
Summary answer Vitrification of human sperm using sucrose and dextran-based cryoprotectant (CPA4) with a new vitrification
device resulted in significantly better sperm motility and progressive motility and improved DNA integrity with lower DNA
fragmentation compared with conventional slow freezing.
What is known already A major limitation to clinical implementation of vitrification is the right balance between the volume of
spermatozoa suspension cryopreserved and a standardised use of CPAs for survival of spermatozoa.
Study design, size, duration This was a control versus current clinical practice study using 30 fresh human semen samples to
carry out the different cryoprotectant analyses followed by a further 23 semen samples to test the novel vitrification protocol.
Participants/materials, setting, methods All human specimens fulfilled the following criteria: > 5 million spermatozoa/mL, >
20% total motility, ≥ 1.8 mL in volume, with all participants falling within the age range of 25–45 inclusively. The concentration,
progressive motility, non-progressive motility, immotility, and various morphokinetic variables including DAP, DCL, DSL, LIN,
and STR were then determined using the IVOS II™ Clinical CASA system (Hamilton Thorne, Beverly, MA, USA) on the basis
of the 5th Edition of WHO Laboratory Manual for the Examination and Processing of Human Semen.
Main results and the role of chance Among the 6 cryopreservation methods in this study, vitrification with the funnel-shaped
device using CPA4 best preserves the 13 sperm parameters evaluated by CASA system. Conventional slow freezing and
vitrification with the device using seminal plasma also protects sperm quality, but the overall motilities are statistically lower
in comparison with the novel vitrification approachwith cryoprotectivemedia using the device. DNA fragmentation significantly
increased after cryopreservation through themethod of conventional slow freezing (p = 0.07). There was no significant difference
in DNA fragmentation between fresh control and vitrification (p = 1.000).
Limitations, reasons for caution Extensive training is required to minimise the human error in using the vitrification device to
perform cryopreservation. Each operator can only handle one sample at a time with device vitrification, whereas several samples
can be processed without the need for special training with conventional slow freezing.
Wider implications of the findings The presented study shows that a new vitrification method could improve survival sperm rate.
Human sperm vitrification using our novel protocol gives higher motility and progression and lower percentage of DNA
fragmentation than conventional slow freezing. Our findings indicate that this method could supersede the current clinical
practice in particular for patients with oligospermia as it reduces osmotic damage, time, and cost.
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Introduction
Sperm cryopreservation is a core-assisted reproductive tech-
nology (ART) procedure for the preservation of male fertility,
particularly useful in oncology patients, vasectomy, or other
obstructive surgeries, gamete donation programmes,
minimisation of sexually transmitted disease transmission, or
when male partner is unable to provide an adequate sample on
the day of ovum pickup. Since the initial report of human
sperm freezing [1], slow freezing, which is a method of step-
wise cooling over a period of 2–4 h and involves the use of
permeable cryoprotectants, continued to be the most common-
ly used technique for sperm cryopreservation [2]. However,
the long exposure of sperm cells to cryoprotectants can cause
physical and chemical damage to the sperm function due to ice
crystal formation and osmotic stress [3–5].
Vitrification is now the most popular and more successful
method for freezing eggs and embryos in clinical ART labo-
ratories [6]. Vitrification requires higher cooling rates and
higher concentrations of cryoprotectants (CPA) in order to
bypass the ice formation stage and move into glass solidifica-
tion instead [7]. However, this method cannot be directly
reproduced on spermatozoa [8], due to the high concentrations
of permeable CPAwhich can be damaging to sperm cells. The
first reports of successful human sperm vitrification were de-
scribed by Isachenko and colleagues [9] without cryoprotec-
tants, and again with sucrose [10]. Improvements on the meth-
odology of vitrification included the copper loop approach,
where a thin film of sperm suspension was created by dipping
the loop into sperm suspension then plunged directly into
liquid nitrogen [11]. Other methods such as microdroplets,
open-pulled straw (OPS), and open-standard straw systems
were also proposed [8]. More recently, a novel sperm vitrifi-
cation device for small number of spermatozoa was also re-
ported with promising results [12].
The small total volume of spermatozoa suspension cryopre-
served by various vitrification systems, such as cryoloops and
OPS is another major limitation hindering the routine application
of vitrification in clinical settings [13], as the small number of
spermatozoa present in such small volume of suspension has
seen limited use for IUI, IVF, or other ART procedures apart
from ICSI [14, 15]. In addition, limited sperm vitrification sys-
tems have been shown to be feasible alternatives [11].
The present study was a twofold investigation, first to com-
pare different compositions of sperm vitrification media and sec-
ond to compare distinct methods of sperm cryopreservation on
post-thaw survival criteria. The initial study compared five vitri-
fication cryoprotectants (CPAs 1-5) using the novel vitrification
device and unfrozen samples. Post-thaw sperm parameters were
examined comparing the cryoprotective efficacy of different
freezing techniques and CPAs using computer-assisted sperm
analysis systems (CASA). CPA4 which demonstrated the best
survival rate of spermatozoa post-warming was used in the sec-
ond arm of the study. In the second part of the work, different
protocols of sperm cryopreservation were compared, namely
conventional slow freezing with cryoprotectant (SFCPA); slow
freezing with seminal plasma (SFSEM); direct vitrification in a
cryovial with CPA (VITCPA); direct vitrification in a cryovial
with seminal plasma (VITSEM); vitrification using a new vitri-
fication device in a cryovial with CPA (VITDCPA); and vitrifi-
cation using the new vitrification device in a cryovial with sem-
inal plasma (VITDSEM). Conventional slow freezing was car-
ried out as a reference of the performance of current human
sperm cryopreservation protocols. Post-thaw survival was
assessed using WHO sperm parameters and morphokinetic var-
iables using computer-assisted sperm analysis (CASA) software;
DNA damage was measured using a Sperm Chromatin
Dispersion (SCD or Halo) test (HALOsperm) and compared
between methods to evaluate the most effective way to cryopre-
serve large volumes of human spermatozoa.
Materials and methods
Semen collection
This study was approved by the UCL Research Ethics
Committee and the NHS Research Ethics Committee
(REC reference, 05/Q0502/143). Written informed consent
was obtained from all patients of the Reproductive
Medicine Unit in University College London Hospital to
participate in this research study. Thirty fresh semen sam-
ples were used in the first part of this study to carry out the
different cryoprotectant analyses, and this was followed by
a further 23 samples to test the novel vitrification protocol.
All specimens fulfilled the following criteria: > 5million
spermatozoa/mL, > 20% total motility, ≥ 1.8 mL in volume,
with all participants falling within the age range of 25–45.
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Obtaining human seminal fluid
A volume of 1 mL of the raw semen sample from the partic-
ipant’s ejaculate was centrifuged for 10 min at 3500×g. The
seminal supernatant was aliquoted into a fresh tube without
disturbing the pellet to use as cryoprotectants.
Semen analysis
Sperm parameters were reported after sperm washing (post-
prep control), and after thawing/warming. Semen analyses
were performed by loading 5 μL of respective samples into
the chambers of Leja disposable counting slides (20 μm
depth; Leja, Nieuw-Vennep, The Netherlands), where the
samples were allowed to fill up the chambers by capillary
action. The concentration, progressive motility, non-
progressive motility, immotility and various morphokinetic
variables including DAP, DCL, DSL, LIN (VSL/VCL), and
STR (VSL/VAP) were then determined using the IVOS II™
Clinical CASA system (Hamilton Thorne, Beverly, MA,
USA) on the basis of the 5th Edition of WHO Laboratory
Manual for the Examination and Processing of Human
Semen. Post-thaw samples with concentrations lower than
0.20 × 106/mL were however analysed by only assessing
100 sperm. Raw semen samples that were of concentration
higher than the operational range of the CASA system (60 ×
106/mL) were diluted accordingly with pre-warmed (37 °C)
QUINN’s™ Sperm-Washing Medium (gentamicin, 5.0 mg/
mL HSA; SAGE; Trumbull, USA).
Vitrification media
Five vitrification media compositions were supplied by
Kitazato BioPharma, Shizuoka, Japan, for evaluation as
follows:
CPA1-0.5 M sucrose with 20% hydroxypropyl cellulose
(HPC) (1000 mOsm)
CPA2-0.5 M sucrose without HPC
CPA3-0.3 M sucrose with HPC (1000 mOsm)
CPA4*-0.3 M sucrose with 20% (v/v)
dextran supplement
CPA5-0.3 M sucrose, 7.5% (v/v) DMSO and ethylene
glycol, and 20% dextran serum supplement.
*From all above-mentioned CPAs, CPA4 gave the best
survival rates and was used for reminder of the study.
Sperm preparation by density gradient centrifugation
Two-layer discontinuous density gradient (45% and 90%)
method was employed to isolate spermatozoa and other con-
stituents of semen and to fractionate subpopulations of
spermatozoa according to their motility. Forty-five percent
and ninety percent of gradient solutions were prepared before-
hand by diluting Sperm Preparation Media (MediCult Origio,
Berlin, Germany) with sperm-washing medium. A minimum
of 1.8 mL of raw semen sample from each participant was
prepared and washed with this protocol. First, a sterile
Pasteur pipette was used to add 1 mL of the top layer gradient
solution (45%) to a centrifuge tube. With a new pipette, 1 mL
of the lower layer (90%) gradient solution was then carefully
loaded from the bottom of the tube, raising the top layer slow-
ly without disruption to create a sharp interface. A maximum
of 1.5 mL of raw semen sample was gently layered on top of
the gradient in each tube. Depending on the amount of raw
semen sample collected from the patient, multiple gradients
were created when necessary. The loaded gradients were later
centrifuged at 300g for 20 min.
After centrifugation, the supernatant was aspirated in a cir-
cular motion from the surface without disrupting the pellet.
Three millilitres of pre-warmed (37 °C) QUINN’s™ Sperm-
Washing Medium was added to a new sterile tube. Using a
Pasteur pipette, the pellet in the centrifuge tube was then as-
pirated and resuspended in the sperm-washing medium. Next,
the mixture was centrifuged for 10 minutes at 300g. The su-
pernatant was removed, leaving behind the pellet. Finally, the
test wash sample was generated by resuspending the pellet in
1.2 mL of sperm-washing medium and was ready for post-
preparation sperm analysis and subsequent cryopreservation
procedures.
Slow freezing
Conventional slow freezing was performed bymixing 200 μL
of SpermFreeze™ slow-freezing cryoprotectant (HAS, glyc-
erol, HEPES; FertiPro NV, Beernem, Belgium) drop by drop
with the same volume of washed sperm sample in a cryovial.
The same procedure was performed for slow freezing in sem-
inal fluid, with participant’s seminal plasma in place of the
SFCPA. The mixture was left at in room temperature for
10 min before exposing to liquid nitrogen vapour for 15
min. The sample was then fixed onto a cryocane and plunged
directly into liquid nitrogen at − 196 °C.
Preparation of vitrification solutions
Two hundred microlitres of either the vitrification solution or
seminal plasma of the patient was pipetted and mixed drop by
drop to 200 μL of post-wash sample, with constant shaking to
facilitate thorough mixing of the two. This vitrification cryo-
protectant mix was then allowed to sit in room temperature for
2 min, whereas the seminal fluid mix was allowed to sit for
10 min before the subsequent vitrification procedure.
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Vitrification procedure
Vitrification using vitrification device
A cryovial was screwed to the bottom of the vitrification
device provided by Kitazato BioPharma for sample collec-
tion during the vitrification process. Under the protection of
cryogloves, the vitrification device was grabbed by its plas-
tic handle and slowly immersed into liquid nitrogen held in
a foam box, until the metal part was fully submerged and
cooled. Twenty microlitres of sperm suspension was rapidly
pipetted using a single channel pipette to just above the
surface of the metal part of the device without contacting
the liquid nitrogen. The pipette was lightly shaken to dis-
pense the droplet of sample formed at the end of the tip. The
droplet of sample was vitrified instantly into a pearl at the
moment it came into contact with liquid nitrogen that was
covering the device. The vitrified pearl was then funnelled
through the canals of the device into the cryovial as shown
in Fig. 1. After collecting around 10 pearls, the device was
removed from the liquid nitrogen, and the cryovial was
unscrewed from the device, then capped. The procedure
was repeated until all sperm suspension was vitrified,
resulting in about 20 pearls in total, stored in 2 separate
vials. The vitrification sample was then ready for temporary
storage in liquid nitrogen tanks.
Vitrification directly into cryovial
After standing in room temperature for the designated
time to allow full incorporation of the media or seminal
fluid with the sperm samples, the cryovials were plunged
directly into liquid nitrogen.
Thawing and warming
All specimens were thawed after storage for a minimum of 24 h.
Slowly frozen samples and those vitrified directly
into cryovials
Cryovials of frozen samples were removed from liquid nitro-
gen and were allowed to thaw at room temperature for 15–20
min until complete transition into liquid state.
Samples vitrified with vitrification device
Labelled new round bottom tubes were filled with 2 mL of
sperm-washing medium at room temperature prior to
warming, each designated for warming vitrified pearls within
1 cryovial. Cryovials containing the vitrified samples were
taken out one at a time from liquid nitrogen, and the vitrified
pearls were poured one by one into a small sterile tray. The
vitrified sperm suspension pearls were quickly picked up by
tweezers and dropped into sperm-washing medium one after
the other. The tube was shaken lightly to facilitate warming
and incorporation of sperm samples into the sperm-washing
medium. A new pearl was placed into the sperm-washing
medium when the previous one had completely warmed.
Spermatozoa preparation for analysis
after cryopreservation procedures
Each slowly frozen sample and those directly vitrified in a
vial were transferred and mixed into 2 mL of sperm-
washing medium in fresh tubes after thawing/warming.
All frozen/thawed and vitrified/warmed samples were
Cryovial
Vitrified pearls of sperm
samples
Liquid nitrogen
Vitrification device
20µL of sperm suspension
pipetted just above the
surface of the device
Fig. 1 Diagram and photo of the
vitrification device and the
vitrification process. Twenty
microlitres of post-preparation
sperm suspension are loaded just
above the vitrification device that
pre-immersed in liquid nitrogen
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subsequently centrifuged for 10 min at 1200×g. The su-
pernatant in each tube was discarded, and the pellet ob-
tained from each cryopreservation approach was later re-
suspended in 0.5 mL of sperm-washing medium. The
warmed and washed sperm samples were then ready for
final analysis
DNA fragmentation analysis
Sperm Chromatin Dispersion (SCD) test (HALOsperm) was
used to assess DNA integrity of the samples. The sperm DNA
fragmentation assay was performed immediately after
obtaining the fresh samples. Fragmentation was then mea-
sured after thawing of the two cryopreserved samples. This
was carried out according the manufacturer’s instructions
(Halotech NDA, Madrid, Spain).
Statistical analysis
A series of repeated measures ANOVA tests were per-
formed to analyse differences between results obtained
from the six different cryopreservation approaches, as
well as the difference in initial sperm parameters and
post-thaw parameters of each approach. Two-sided
Dunnett post hoc tests were subsequently carried out on
parameters with statistically significant interactions in
ANOVA. All correlation analysis, also the mean and stan-
dard deviation (SD) calculations, were performed with
SPSS. A p value < 0.05 was considered to be statistically
significant.
Slow conventional freezing was performed as a ref-
erence. The post-thaw sperm parameters of slow freez-
ing were compared against those of vitrification directly
in a cryovial, as well as with those resulting from vit-
rification using a specific vitrification device (Fig. 1) to
give an overview of the effectiveness of the proposed
novel cryopreservation protocols. All vitrification cycles
were performed with our previously evaluated cryopro-
tective media provided by Kitazato BioPharma (0.3 M
sucrose, 20% (v/v) dextran serum supplement). To eval-
uate the protective effect of seminal plasma, each of the
3 approaches above were repeated using seminal fluid
of the patient as a cryoprotectant instead. Six ap-
proaches in total using different cryopreservation
methods and cryoprotective media were performed on
each consented patient sample. Each raw semen sample
was divided into 2 portions, with 1 aliquot ≥ 0.8 mL
semen centrifuged to obtain sperm-free seminal plasma,
and the rest of the fresh raw semen prepared and
washed by density gradient centrifugation. The washed
sample was then subdivided into 6 portions, each of
200 μL for examining each cryopreservation approach.
Results
The effects of composition of vitrification solutions
on sperm survival
Semen samples from 30 different patients were tested (n
= 30). Each sample was prepared through density gra-
dient, and the semen parameters were assessed for con-
centration, motility (PM, NP, and IM), and CASA ki-
netic measurements (DAP, DCL, DSL, LIN, and STR),
and the final volume was divided equally and vitrified
with one of the five vitrification solutions (CPA1-
CPA5). The samples were subsequently warmed, and
the semen parameters were reassessed. All CPAs dem-
onstrate similar concentration post-warming (p > 0.05)
(Table 1). Both motility and progressive motility param-
eters were significantly higher with CPA4 post-warming
compared with all other compositions (Table 1), whilst
CPA5 resulted in a significantly lower motility and pro-
gressive motility post-warming (Table 1).
No significance was demonstrated between CPA3,
CPA4, and pre-vitrification controls for the majority of
CASA kinematic measurements (DAP, DCL, DSL, LIN,
and STR, Table 1), which again highlights that CPA4
better post-warming parameters compared with the other
vitrification compositions.
Comparison between seminal fluid and CPA4
vitrification media, with or without the vitrification
device, on sperm parameters after vitrification
and warming
Sperm parameters of 23 semen samples including con-
centration and motility (progressive motile (PM), non-
progressive motile (NP), and immotile (IM) categories)
were assessed, after density gradient centrifugation and
prior to freezing or vitrification (post-wash control), and
immediately after thawing or warming procedure.
VITDCPA4 resulted in a significantly (p < 0.05) higher
motility parameters post-warming (23%, Fig. 2) than all
other post-thaw/warm methods. This was followed by
slow freezing (SFCPA, 12%) and VITDSEM (8%)
which resulted in significantly higher motility results
than VITCPA4 (2%), SFSEM (1%), and VITSEM (1%,
p < 0.05, Fig. 2).
For SFCPA and VITCPA4 groups, CASA kinematic
parameter (DAP, DCL, DSL, LIN, and STR) post-
warming were significantly higher than all other treat-
ment groups (data not shown), which again highlights
that CPA4 and the novel device results in improved
post-warming semen parameters compared with the oth-
er vitrification methods.
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Further analysis of slow freezing versus vitrification
using the novel vitrification device and CPA4
containing 4. 0.3 M sucrose with 20% (v/v) dextran
serum supplement as the cryoprotectant
A further 23 samples were analysed; concentration, total
motility, and progression were found to be significantly
lower in the cryopreserved samples when compared with
the control (p < 0.05, Table 2). Total motility and progres-
sive motility were significantly lower in the slow freezing/
thawing group compared with the control and vitrified/
warmed samples (Table 1).
DNA fragmentation analysis
DNA fragmentation levels were 1.4 times higher in slowly
frozen/thawed samples compared with controls and with vit-
rified warmed samples (p < 0.05), whilst there was no signif-
icant difference in DNA fragmentation between control and
vitrified/warmed samples (Table 2).
Discussion
The present study was designed to improve on sperm vitrifi-
cation methods for larger volume samples which remain at a
proof of principle stage compared with the conventional slow
freezing. We compare five different vitrification solutions that
were supplied from a leading manufacturer of vitrification
media for gametes and embryos. Vitrification using sucrose
and dextran (CPA4) with the new vitrification device resulted
in a significantly better sperm motility and progressive motil-
ity compared with conventional slow freezing. In the present
study, sperm quality that is conventionally estimated by per-
centage of the total motility was significantly reduced after
slow freezing from 77.8 to 21.2% for slow freezing and
30.1% for vitrification (Table 2). The low survival rate is of
particular importance in cases where severe oligozoospermia
and epididymal or testicular samples are given. The main con-
cern with these patients is the technical difficulties when deal-
ing with such small number of cells, the toxic effects of the
CPA’s, and the risk of cross-contamination when an open-
freezing system is used [16, 17]. Additionally, vitrification
Table 1 Comparison of spermatozoa survival rates using 5 different cryoprotectants (CPA1-CPA5) to the post-density gradient control. Numbers given
are mean ± SD, *p < 0.05, +/−p < 0.05 (CPA1 to CPA5 comparison excluding control)
Control CPA1 CPA2 CPA3 CPA4 CPA5
Concentration (M/mL) 46.8* (± 61.1) 23 (± 15.9) 15.7 (± 18.0) 17 (± 20.2) 14.2 (± 15.5) 14.4 (± 15.6)
Total motility (PM + NP, %) 82.2* (± 13.8) 17.7 (± 9.4) 18.6 (± 9.2) 21.9 (± 8.9) 31.2+ (± 11.4) 2.4− (± 2.1)
Progressive motility (%) 53.2* (± 25.8) 5.6 (± 4.3) 5.2 (± 4.9) 9.8 (± 6.4) 15.5+ (± 8.6) 0.8− (± 1.0)
DAP (μm) 15.5* (± 6.7) 11.4 (± 6.0) 10.5 (± 6.2) 14.3* (± 7.9) 14.0* (± 7.7) 10.0 (± 6.4)
DCL (μm) 26.9* (± 12.4) 23.8 (± 11.8) 22.4 (± 12.5) 27.5* (± 13.9) 26.8* (± 13.8) 21.0 (± 13.6)
DSL (μm) 9.7* (± 5.0) 7.9* (± 5.4) 7.1 (± 5.5) 10.7*+ (± 7.3) 10.4*+ (± 7.1 6.4 (± 4.9)
LIN (VSL/VCL, %) 37.8* (± 16.5) 33.7* (± 16.0) 31.2 (± 16.5) 38.3* (± 16.2) 38.0* (± 16.0) 35.0* (± 19.7)
STR (VSL/VAP, %) 64.9 (± 20.8) 66.4 (± 20.1) 64.6 (± 20.9) 71.8 (± 16.2) 70.3 (± 19.5) 65.1 (± 24.4)
A
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)
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W
Sperm cryopreservaon methods
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 PM (%)
Fig. 2 Mean (%) ± SD of PM
(progressive motile), NP (non-
progressive motile), and IM
(immotile) of post-prep test wash
samples prior to freezing and
post-thawed samples cryopre-
served by the 6 different proto-
cols; different letters between
groups indicate statistically sig-
nificant differences at p < 0.05
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of sperm results in significantly lower DNA damage than with
slow freezing as demonstrated by Sperm Chromatin
Dispersion analysis. DNA fragmentation significantly in-
creased after cryopreservation through the method of conven-
tional slow freezing (p = 0.07). There was no significant dif-
ference in DNA fragmentation between fresh control and vit-
rification (p = 1.000).
The average mean DNA fragmentation for slow freezing
was found to be 25.5 ± 17.1 (Table 2), which is 1.39 times
higher as compared with the vitrification group (18.1 ± 12.8).
The lowest DNA fragmentation for slowly frozen samples
was 2% and the highest was 62%. However, in the vitrified
group, the lowest DNA fragmentation rate was 1% and the
highest was 56%.
SPSS assumption of normality gave statistically significant
difference (p value of 0.41) between DNA fragmentation in-
dex of slow freezing and vitrification as shown in Table 2.
These results indicate that vitrification of sperm can be
more effective and efficient for sperm cryopreservation in a
clinical setting. The cryoprotecting efficacy of sucrose was
previously supported by Isachenko et al. reporting a signifi-
cant increase in progressive motility and viability under sup-
plementation of HSA and sucrose [10]. Sucrose was also re-
ported to also independently successfully preserve motility
and viability of sperm among various concentrations of other
saccharides in multiple studies. Sucrose along the high molec-
ular weight dextran which has multiple hydroxide groups that
may help form a protective layer on the sperm surface by
developing hydrogen bonds with the phosphate of the mem-
brane phospholipids.
The purpose of the new funnel vitrification device is to
fractionate the sperm suspension into portions of smaller vol-
umes, so as to maximise the contact surface area with liquid
nitrogen, thus maximising the temperature drop experienced
by each sperm during the vitrification process. Pelleting of
sperm has been used successfully in the ram for breeding
purposes [18, 19]. Successful vitrification of small volume
of semen and the use of vitrification devices were reported
previously [10, 20] by aliquoting a suspension of washed se-
men aliquoted by a single channel pipette into liquid nitrogen
and collected by a strainer, also demonstrated superiority of
suchmethod over conventional freezing. Rapid cooling rate in
liquid nitrogen also greatly shortens the process of change of
state of cellular contents [21, 22], effectively avoiding any
damage resulting from crystallisation action compared with
the 2-stage cooling process in conventional slow freezing
[23]. The immersion and complete cooling of the vitrification
device in LN2 prior to the start of the procedure minimises the
heat insulation effect of film boiling during plunging of the
sample into LN2. Film boiling refers to the strong vaporisation
process of LN2 upon heat flux during plunging of samples
into LN2, resulting in the generation of a layer of vapour
covering the LN2 surface adjacent to the heat surface, which
reduces thermal conductivity and ultimately the cooling rate.
Despite the superiority of this novel device vitrification
approach with vitrification media over conventional slow
freezing, the sperm parameters are still greatly diminished in
comparison with fresh and washed ejaculate. One limitation of
this study would be the warming rate of the pellets which have
been demonstrated previously to be a limiting factor in vitri-
fication procedure [13], and increasing the temperature of
warming to almost 42 °C resulted in faster thawing past the
0 °C and significantly better survival rates and recovery of
motility [24]. It is also worth mentioning that survival of
sperm in this work refers solely to motile function so the
survival has been potentially under reported as live/dead
sperm staining would have highlighted a higher number of
sperm survival [10]. Therefore, future studies in the short term
should focus on optimising the current vitrification device and
media and address the findings in this study with a larger
sample size. However, this method could prove superior in
the short term for severe male factor infertility where small
number of cells are available to freeze.
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Table 2 Comparison of semen parameters between control and frozen/thawed or vitrified/warmed samples. Values are expressed asmean ± SD, *+−p <
0.05
Sperm concentration Motility (PM + NP) Progressive motility (PM) DNA fragmentation
Control 30.1 ± 28.2* 77.8 ± 18.2* 49.5 ± 23.3* 16.3 ± 12.9
Slow freezing 9.7 ± 11.2 21.2 ± 10.2− 7.2 ± 6.2- 25.5 ± 17.1*
Vitrification 10.0 ± 13.9 30.1 ± 10.9+ 16.2 ± 7.4+ 18.1 ± 12.8
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